Organic Active Ingredients TRIZ Cases

A composite adhesive layer blends rubber and silicone bases with butorphanol to maintain adhesion stability under warm water or high humidity.

CHP combined with zinc reduces oxidative stress to restore beta-cell function without conventional drug side effects.

Crystal Form A of a tricyclic compound exhibits enhanced stability and reduced hygroscopicity through controlled recrystallization.

Cycloalkyl pyrazolopyrimidine compounds replace toxic ribavirin and expensive monoclonal antibodies with an effective oral treatment.

Novel heterocyclic compound potentiates AMPA receptor function to treat depression and Alzheimer's disease.

Specific sialylated glycans extracted from breast milk prevent bronchitis onset, addressing the lack of effective preventive methods for vulnerable groups.

AAV vectors transport TCAP cDNA to muscle cells, enabling long-term protein expression to treat telethoninopathies like LGMDR7.

A pyrrole derivative acts as a potassium-competitive acid blocker to suppress gastric secretion.

Membrane filtration concentrates ellagitannins from blackberry extracts, eliminating solvent residues and reducing energy costs.

Targeted polyester nanoparticles deliver repair agents to injured brain endothelium, resolving systemic distribution limits.

D-Alanine phosphoramidate pronucleotides enhance bioavailability and efficacy against hepatitis C virus infections.

AM211 DP-2 antagonist blocks PGD2 receptors to stimulate hair growth, addressing unclear mechanisms in androgenetic alopecia treatments.

Analyzing TET1 promoter hypermethylation identifies early-stage cancer risks, resolving the bottleneck of late diagnosis and poor prognosis.

Trioxane thioacetals combine artemisinin with parasiticidal amines to deliver single-dose efficacy, resolving compliance issues from multi-dose regimens.

Quantifying mean interglomerular area differentiates primary from maladaptive FSGS, reducing unnecessary immunosuppressive therapy.

Repeated equal doses of anti-FcεRIα monoclonal antibodies induce rapid allergen desensitization without triggering severe anaphylactic reactions.

High-speed homogenization produces a stable amlodipine dry suspension without surfactants, enabling easier pediatric dosing and industrial scalability.

Formula I compounds inhibit plasmepsin X and IX proteases, blocking parasite egress while reducing drug resistance risks.

NSI-189 treats depression in cognitively impaired patients by matching 80 mg doses to EEG biomarkers, resolving trial-and-error medication selection.

Gamma-sterilized tacrolimus formulation reduces ocular irritation while suppressing adaptive immune responses.

Dual siRNA compositions silence TGF-β and PD-L1 to overcome immunosuppression in liver cancer.

Baobab extract and alginate enable dual-phase delivery, resolving the trade-off between rapid onset and sustained action in oral formulations.

Humanized anti-Nectin-4 antibody drug conjugate uses a PEG3-Val-Cit linker to enhance endocytosis and targeting specificity.

A compounded topical cream formulation utilizes dimethyl sulfoxide to enhance transdermal delivery of active pharmaceutical ingredients.

Modified quinazolinone structures reduce paradoxical MAPK activation in wild-type BRAF, preventing secondary tumor growth and drug resistance.

Administering delta-aminolevulinic acid accumulates porphyrins in tumors, enabling detection via HPLC or fluorescence without isotopes.

Intravenous manuka honey co-administration with paclitaxel reduces systemic toxicity while maintaining anti-cancer efficacy.

Non-aqueous propylene glycol formulation prevents hydrolytic degradation, extending shelf life and reducing myelosuppression.

Lipophilic vegetable oils stabilize 1-acetoxychavicol acetate against thermal degradation, maintaining efficacy over ten weeks without extra additives.

Optimized compaction pressure between 200 to 290 MPa balances tablet tensile strength against disintegration time, preventing crumbling during handling.

Halofuginone suppresses inflammatory responses and neuronal cell death to delay ALS symptom progression and extend survival duration.

Inorganic nitrate composition reduces oxygen consumption while delaying fatigue, maintaining safety by preventing hypotension and methemoglobinemia.

Segmented tablet designs prevent chemical incompatibility and mask unpleasant taste while delivering rapid liver protection against acetaminophen overdose.

Combining BET bromodomain inhibitors with fulvestrant or abemaciclib targets estrogen receptor positive breast cancer cells.

Computational models using sex-specific polygenic risk scores determine hormone levels from genetic data.

Novel matrine α-ketoamine derivatives inhibit TNF-α overexpression and activate NK cell immune killing functions.

Pyridopyrimidine derivatives inhibit cGMP accumulation induced by E. coli heat stable toxin, resolving ineffective existing treatments for diarrhea.

Inhibiting TGFβ signaling delays stem cell quiescence return, resolving slow regeneration after chemotherapy stress.

Segmented peptides targeting p32 activate the CendR pathway to penetrate plaques, reducing plaque load while minimizing systemic side effects.

Calcifediol mitigates inflammatory processes via high affinity receptor binding, reducing ICU admission rates and mortality compared to corticosteroids.

Glycyrrhiza plant extracts bind and neutralize polypeptide fungitoxins, resolving toxicity issues in animal feed.

Unnatural amino acid polymers form stable complexes that deliver mRNA to cartilage, reducing systemic side effects while slowing osteoarthritis progression.

A pharmaceutical composition combining a cyclized peptide with a neuraminidase inhibitor to enhance therapeutic efficacy against influenza.

An L-RNA aptamer binds to the amyloid precursor protein 3′-untranslated region G-quadruplex structure.

A multi-step solvent immersion and chromatography process isolates pure palytoxin from marine polyps.